U.S. Plasmid DNA Manufacturing Market Strengthened by Expanding Cell Therapy Pipelines
The U.S. Plasmid DNA Manufacturing Market is gaining significant momentum as the rapid advancement of cell and gene therapies increases demand for high-quality plasmid DNA manufacturing solutions. Plasmid DNA has become an essential raw material in the development of advanced therapeutics, serving as the genetic backbone for viral vectors, gene editing technologies, and DNA-based medicines. As...
0 Comments
0 Shares